Exclude Patient Type Detail Header
No
Footnote
<sup>12</sup> Atorvastatin 40 mg: evidence from 1 RCT only after down-titration from 80 mg due to intolerance. <br><br>
<sup>13</sup> Rosuvastatin 40 mg not included in RCTs.
<br><br>
<sup>14</sup> Mod-intensity: Other FDA-approved options not included in RCTs: atorvastatin 20 mg, rosuvastatin 5 mg, pravastatin 80 mg, fluvastatin XL 80 mg, pitavastatin 2-4 mg. Although simvastatin 80 mg was studied, this dose is not FDA-recommended d/t myopathy risk.
<sup>13</sup> Rosuvastatin 40 mg not included in RCTs.
<br><br>
<sup>14</sup> Mod-intensity: Other FDA-approved options not included in RCTs: atorvastatin 20 mg, rosuvastatin 5 mg, pravastatin 80 mg, fluvastatin XL 80 mg, pitavastatin 2-4 mg. Although simvastatin 80 mg was studied, this dose is not FDA-recommended d/t myopathy risk.
Detail Type
Text